Contact this trialFirst, we need to learn more about you.
MEK Inhibitor
Trametinib for Ovarian Cancer
Recruiting1 awardPhase 2 & 3
Walla Walla, Washington
This trial is studying how well trametinib works compared to standard treatments for ovarian or peritoneal cancer that has come back or spread to other parts of the body.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.